Abstract
The in vitro activity of trospectomycin was compared to that of amikacin, cephalothin and vancomycin against gram-positive organisms, mostly isolated from cancer patients. Trospectomycin was considerably more active than amikacin against most isolates tested, particularly species ofStaphylococcus andStreptococcus. Overall, vancomycin was the most active agent tested.
Similar content being viewed by others
References
Brown, A. E. Neutropenia, fever and infection. American Journal of Medicine 1984, 11: 421–428.
Jacobus, N. V., Tally, F. P. Activity of trospectomycin againstBacteroides fragilis and other bacteroides species. Antimicrobial Agents and Chemotherapy 1988, 32: 584–586.
Karchmer, A. W. Antibiotic therapy of nonenterococcal streptococcal and staphylococcal endocarditis: current regimens and some future considerations. Journal of Antimicrobial Chemotherapy 1988, 21, Supplement C: 91–103.
Novak, E., Schlagel, C. A., LeZotte, L. A., Pfeifer, R. T. The tolerance of high-dose intravenous spectinomycin therapy in man. Journal of Clinical Pharmacology 1974, 14: 442–447.
Zurenko, G. E., Yagi, B. H., Vaura, J. J., Wentworth, B. B. In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog. Antimicrobial Agents and Chemotherapy 1988, 32: 216–223.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rolston, K., Ho, D.H. & Bodey, G.P. In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients. Eur. J. Clin. Microbiol. Infect. Dis. 8, 254–256 (1989). https://doi.org/10.1007/BF01965272
Issue Date:
DOI: https://doi.org/10.1007/BF01965272